Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share (ORKA)

Q: What does CUSIP 687604108 represent in this 13F holders report?

CUSIP 687604108 is the security identifier for ORKA - Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held ORKA - Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share in Q2 2025?

81 institutional investors reported ORKA - Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 687604108

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class: Equity / Common Stock, $0.001 par value per share
Total 13F shares: 34,429,035
Total 13F value: $385,950,468
Share change: +2,650,212
SEC-reported price per share: $11.21
Number of holders: 81
Value change: +$30,431,109
Number of buys: 51
Number of sells: 29
Shares outstanding: 74,732,908

Security key

687604108

Report period

Q2 2025

Institutions

Top holders

ORKA full security history Ownership snapshot Full 13F holder table Oruka Therapeutics, Inc. SEC filings Oruka Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ORKA - Oruka Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

FMR LLC

Disclosed value leader

FMR LLC

Comparable rows

15/15

Latest evidence

31 Mar 2025

13F Lead comparable stake: 7.4% Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 7.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.

Comparable ownership Top 5

FMR LLC 7.4%

Venrock Adviser, LLC 5.6%

Fairmount Funds Management LLC 4.5%

RTW INVESTMENTS, LP 2.6%

VANGUARD GROUP INC 2.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
FMR LLC	13F Company 13F	7.4%	$57,064,150 5,561,808 shares	—	31 Mar 2025
Venrock Adviser, LLC	13F Company 13F	5.6%	$42,562,871 4,148,428 shares	—	31 Mar 2025
Fairmount Funds Management LLC	13F Company 13F	4.5%	$34,595,920 3,371,922 shares	—	31 Mar 2025
RTW INVESTMENTS, LP	13F Company 13F	2.6%	$19,962,359 1,945,649 shares	—	31 Mar 2025
VANGUARD GROUP INC	13F Company 13F	2.2%	$16,800,063 1,637,433 shares	—	31 Mar 2025
BRAIDWELL LP	13F Company 13F	2.1%	$16,133,091 1,572,426 shares	—	31 Mar 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

34,429,035

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Q2 2025 holders

Holder diff

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 value	Q2 2025 value	Value change	Value Chg %